These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3135738)

  • 21. Nature of inducible ventricular tachyarrhythmias in a canine chronic myocardial infarction model.
    Echt DS; Griffin JC; Ford AJ; Knutti JW; Feldman RC; Mason JW
    Am J Cardiol; 1983 Nov; 52(8):1127-32. PubMed ID: 6637836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in incidence of inducible ventricular tachycardia after myocardial infarction by treatment with streptokinase during infarct evolution.
    Bourke JP; Young AA; Richards DA; Uther JB
    J Am Coll Cardiol; 1990 Dec; 16(7):1703-10. PubMed ID: 2254557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size.
    Pizzetti G; Belotti G; Margonato A; Carlino M; Gerosa S; Carandente O; Chierchia SL
    Eur Heart J; 1996 Mar; 17(3):421-8. PubMed ID: 8737217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction.
    Buxton AE; Simson MB; Falcone RA; Marchlinski FE; Doherty JU; Josephson ME
    Am J Cardiol; 1987 Jul; 60(1):80-5. PubMed ID: 3604948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of extrastimulus prematurity and intraventricular conduction time in inducing ventricular tachycardia or ventricular fibrillation secondary to coronary artery disease.
    Gillis AM; Winkle RA; Echt DS
    Am J Cardiol; 1987 Sep; 60(7):590-5. PubMed ID: 3630942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of helicopter transport and out-of-hospital intravenous fibrinolytic therapy in patients with evolving myocardial infarction.
    Topol EJ; Fung AY; Kline E; Kaplan L; Landis D; Strozeski M; Burney RE; Pitt B; O'Neill WW
    Cathet Cardiovasc Diagn; 1986; 12(3):151-5. PubMed ID: 3089627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic characteristics of ventricular tachycardia or fibrillation in relation to age of myocardial infarction.
    Stevenson WG; Brugada P; Kersschot I; Waldecker B; Zehender M; Geibel A; Wellens HJ
    Am J Cardiol; 1986 Feb; 57(6):387-91. PubMed ID: 3946252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reperfusion arrhythmias in acute myocardial infarction].
    Gao R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):84-6, 133. PubMed ID: 1473486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The frequency of early coronary reperfusion assessed by electrocardiographic criteria in relation to the timing of thrombolytic therapy in acute myocardial infarct].
    Maugeri Saccà C; Arrigo F; Costa G; Cavalli A; Giannetto M; Virga T; Cento D; La Presa V
    Minerva Cardioangiol; 1992 Mar; 40(3):65-9. PubMed ID: 1630677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right ventricular dysfunction predisposes to inducible ventricular tachycardia at electrophysiology studies in patients with acute ST-segment-elevation myocardial infarction and reduced left ventricular ejection fraction.
    Thakkar JB; Zaman S; Byth K; Narayan A; Thiagalingam A; Chow C; Thomas SP; Sivagangabalan G; Farlow D; Barnett R; Kovoor P
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):898-905. PubMed ID: 25108742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators.
    Newby KH; Thompson T; Stebbins A; Topol EJ; Califf RM; Natale A
    Circulation; 1998 Dec; 98(23):2567-73. PubMed ID: 9843464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis.
    de Paola AA; Horowitz LN; Miyamoto MH; Pinheiro R; Ferreira DF; Terzian AB; Cirenza C; Guiguer N; Portugal OP
    Am J Cardiol; 1990 Feb; 65(5):360-3. PubMed ID: 2301265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia.
    Buxton AE; Kleiman RB; Kindwall KE; Josephson ME
    Am J Cardiol; 1993 Mar; 71(8):695-8. PubMed ID: 8447267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.